Rivaroxaban Management for Dental Extraction

Evidence-Based Approach

For simple dental extractions (1-3 teeth), the European Heart Rhythm Association recommends continuing rivaroxaban without interruption and performing the procedure with local hemostatic measures, as these procedures are classified as "minor bleeding risk" 1, 2
The American College of Chest Physicians found no significant increase in bleeding when continuing anticoagulation for minor dental procedures, with bleeding rates remaining low (approximately 5%) and self-limiting 2
Local hemostatic measures, including tranexamic acid mouthwash, fibrin glue, topical hemostatic agents, and sutures, should be applied to minimize bleeding risk 2
The European Heart Rhythm Association recommends avoiding NSAIDs in the perioperative period to minimize bleeding risk 1

Rivaroxaban has a half-life of 7-11 hours, and a 24-hour interruption provides approximately 2-3 half-lives of clearance, reducing anticoagulant effect to approximately 25% of peak 3, 4
For patients with renal impairment (CrCl 30-50 mL/min), the American Society of Hematology recommends considering extending interruption to 48 hours, as one-third of rivaroxaban is renally eliminated 4

The American College of Cardiology explicitly recommends against using bridging anticoagulation with heparin or low-molecular-weight heparin during rivaroxaban interruption for dental procedures, as it increases hemorrhagic risk without reducing thrombotic events 5
The American Society of Hematology recommends pausing rivaroxaban treatment 24 hours before low-risk bleeding procedures in pediatric patients, though this is extrapolated from adult data 3, 6